Verrica Pharmaceuticals Inc. (VRCA) stock
VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.88+0.03 (+1.05%)
Close on Nov 19, 2026Market cap $49.56MP/E –Yield –
Verrica Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Verrica Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2025 was -$17.63M. For fiscal 2025 it was -$17.63M. The highest annual figure on record is -$17.63M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$17.63M | – |
| FY2024 | Dec 31, 2024 | -$60.95M | – |
| FY2023 | Dec 31, 2023 | -$38.94M | – |
| FY2022 | Dec 31, 2022 | -$18.95M | – |
| FY2021 | Dec 31, 2021 | -$28.47M | – |
| FY2020 | Dec 31, 2020 | -$31.68M | – |
| FY2019 | Dec 31, 2019 | -$28.09M | – |
| FY2018 | Dec 31, 2018 | -$18.65M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$4.59M | – |
| Q3 FY2025 | Sep 30, 2025 | $9.69M | – |
| Q4 FY2024 | Dec 31, 2024 | -$16.06M | – |
| Q3 FY2024 | Sep 30, 2024 | -$8.57M | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.37M | – |
| Q1 FY2024 | Mar 31, 2024 | -$19.95M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.73M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.88M | -951.0% |
| Q2 FY2023 | Jun 30, 2023 | -$4.73M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.60M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.02M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.75M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.34M | -433.0% |
| Q1 FY2022 | Mar 31, 2022 | -$8.35M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.94M | – |
| Q3 FY2021 | Sep 30, 2021 | -$10.64M | – |
| Q2 FY2021 | Jun 30, 2021 | $2.20M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.10M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.64M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.72M | – |
| Q2 FY2020 | Jun 30, 2020 | -$8.71M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.61M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.22M | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.55M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.15M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.77M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.17M | – |
See a number that looks wrong?